COSMOS HEALTH INC. Depreciation Expense on Reclassified Assets
COSMOS HEALTH INC. (COSM) reported Depreciation Expense on Reclassified Assets of $453.95 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DepreciationExpenseOnReclassifiedAssets · last filed 2026-04-15
- COSMOS HEALTH INC. depreciation expense on reclassified assets for the quarter ending 2025-12-31 was $109.79K, a 35.69% increase year-over-year.
- COSMOS HEALTH INC. depreciation expense on reclassified assets for the quarter ending 2025-09-30 was $131.61K, a 46.73% increase year-over-year.
- COSMOS HEALTH INC. depreciation expense on reclassified assets for the quarter ending 2025-06-30 was $97.54K, a 5.81% decline year-over-year.
- COSMOS HEALTH INC. depreciation expense on reclassified assets for the quarter ending 2025-03-31 was $97.54K, a 13.59% decline year-over-year.
- COSMOS HEALTH INC. depreciation expense on reclassified assets for fiscal 2025 was $453.95K, a 17.29% increase from fiscal 2024.
- COSMOS HEALTH INC. depreciation expense on reclassified assets for fiscal 2024 was $387.04K.
| Period end | Depreciation Expense on Reclassified Assets 3 month | Depreciation Expense on Reclassified Assets 6 month | Depreciation Expense on Reclassified Assets 9 month | Depreciation Expense on Reclassified Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $109.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $241.40K derived: sum of 2 quarters · filed 2026-04-15 | $338.94K derived: sum of 3 quarters · filed 2026-04-15 | $453.95K 10-K · filed 2026-04-15 |
| 2025-09-30 | $131.61K 10-Q · filed 2025-11-14 | $229.15K derived: sum of 2 quarters · filed 2025-11-14 | $344.17K 10-Q · filed 2025-11-14 | $407.60K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-06-30 | $97.54K 10-Q · filed 2025-08-18 | $212.55K 10-Q · filed 2025-08-18 | $275.99K derived: sum of 3 quarters · filed 2026-04-15 | $365.68K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-03-31 | $97.54K 10-Q · filed 2025-05-15 | $178.45K derived: sum of 2 quarters · filed 2026-04-15 | $268.14K derived: sum of 3 quarters · filed 2026-04-15 | $371.70K derived: sum of 4 quarters · filed 2026-04-15 |
| 2024-12-31 | $80.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $170.60K derived: sum of 2 quarters · filed 2026-04-15 | $274.16K derived: sum of 3 quarters · filed 2026-04-15 | $387.04K 10-K · filed 2026-04-15 |
| 2024-09-30 | $89.69K 10-Q · filed 2025-11-14 | $193.25K derived: sum of 2 quarters · filed 2025-11-14 | $306.13K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $103.56K 10-Q · filed 2025-08-18 | $216.43K 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $112.87K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |